bone
-
Biologics
Bioventus Receives FDA Clearance of Strip Format of its SIGNAFUSE® Bioactive Bone Graft
June 25, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching its SIGNAFUSE Bioactive Bone Graft in a new…
Read More » -
Biologics
Biogennix Remains Operational as it Prepares for Post-Coronavirus Surgical Demand
IRVINE, Calif. — April 14, 2020 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft…
Read More » -
Biologics
Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable Bone Grafting Solution in Spine Procedures
March 04, 2020 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More » -
Biologics
Bioventus Recognizes 25 Years of Proven Bone Healing from EXOGEN
February 24, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is recognizing 25 years of proven bone healing…
Read More » -
Regulatory
Orthofix Announces FDA Approval of STIM onTrack 2.1 Mobile App for Bone Growth Stimulators
February 13, 2020 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies,…
Read More » -
Regulatory
Silver Bullet Therapeutics Secures CE Mark Approval for Revolutionary New Antimicrobial Bone Screw System
January 09, 2020 SAN JOSE, Calif.–(BUSINESS WIRE)–Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that it has…
Read More » -
Biologics
Royal Biologics announces the launch of MAGNUS, a DMSO-free viable cellular bone allograft
JANUARY 08, 2020 Royal Biologics, an ortho-biologics company specializing in the research and advancement of regenerative cellular therapy and novel…
Read More » -
Biologics
Bone Biologics Preclinical Study Shows rhNELL-1 Effectively Promotes Bone Formation
January 7, 2020 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for spine fusion, trauma and osteoporosis…
Read More » -
Spine
TheraCell Announces Launch Of Demineralized Bone Fiber Anchor For Pedicle Screws
LOS ANGELES, Sept. 24, 2019 /PRNewswire/ — TheraCell Inc., a leading bone solution company today announced that it will launch the world’s first ever…
Read More » -
Biologics
Researchers have Developed a Protein-Loaded Antimicrobial Hydrogel to Treat and Prevent Bone Infections
09/09/2019 / ORTHOPEDIC BIOMATERIALS Bone infections are notoriously tricky to treat, and antibiotics are frequently prescribed. Now, researchers at Georgia…
Read More » -
Biologics
Biogennix Launches Agilon Bone Grafting Solution
September 04, 2019 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More » -
Hospitals
SpineGuard Extends the Utility of Its Dynamic Surgical Guidance (DSG ™) Technology Platform by Receiving US Patent for “Bone Quality Measurement” Application
PARIS & SAN FRANCISCO–(BUSINESS WIRE)– SpineGuard (FR0011464452 – ALSGD), an innovative company that develops and markets disposable medical devices to…
Read More » -
Hospitals
UK based medical device company announces two new patents granted by the US Patent and Trademark Office
SIRAKOSS Ltd., a UK-based medical device company developing innovative bone grafting solutions for the $3 billion global orthopaedic market, has…
Read More »